Current Report Filing (8-k)
April 05 2023 - 4:31PM
Edgar (US Regulatory)
0001590560
false
00-0000000
0001590560
2023-03-31
2023-03-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 31, 2023
uniQure N.V.
(Exact Name of Registrant as Specified in
Charter)
The Netherlands |
|
001-36294 |
|
N/A |
(State or Other
Jurisdiction of Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
Paasheuvelweg 25a,
1105 BP Amsterdam, The Netherlands |
|
N/A |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: +31-20-566-7394
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: |
|
Trading Symbol(s) |
|
Name of each exchange on which
registered: |
Ordinary
Shares, par value €0.05 per share |
|
QURE |
|
The Nasdaq Stock Market LLC
The Nasdaq Global Select Market |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Alex Kuta, Chief Regulatory Officer of
uniQure N.V. (the “Company”), has retired from the Company and its affiliates in all capacities, effective
March 31, 2023 (the “Retirement Date”). In connection with his retirement, Dr. Kuta’s employment
agreement, dated August 20, 2019, terminated as of the close of business on the Retirement Date, other than those provisions
that survive termination by their terms.
In furtherance of the Company’s succession
plans, Dr. Kuta and uniQure, Inc., an affiliate of the Company, entered into a consulting agreement (the “Consulting
Agreement”) on March 31, 2023 for a term of one year. Under the terms of the Consulting Agreement, Dr. Kuta will
provide consulting services related to the transition of the regulatory and related functions and other regulatory consulting
services that may be reasonably requested. In consideration, Dr. Kuta will (a) receive a consulting fee equal to $15,000 per month,
(b) remain eligible during the term of the Consulting Agreement to receive continued vesting of any previously granted equity
awards in effect as of the Retirement Date, and (c) receive the cost of coverage incurred by Dr. Kuta for any group medical
and/or dental insurance pursuant to the federal “COBRA” law during the term of the Consulting Agreement.
The foregoing description of
the material terms of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full
text of the Consulting Agreement, a copy of which will be filed with the Securities and Exchange Commission as an exhibit to the Company’s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
UNIQURE N.V. |
|
|
Date: April 5, 2023 |
By: |
/S/ DAVID J. CERVENY |
|
|
David J. Cerveny |
|
|
Chief Legal Officer |
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024